Loading field map
Biomechanics has never been a single, unified way of studying living movement and structure. Since the late nineteenth century, researchers have approached the same basic question—how do biological systems generate, transmit, and resist forces?—from fundamentally different angles. The result is a field composed of distinct frameworks that sometimes build on each other, sometimes compete, and often coexist because each captures a different slice of biological reality. Understanding biomechanics means understanding this layered history of frameworks, each defined by its own assumptions about what matters most: the geometry of motion, the material properties of tissues, the behavior of cells, or the integration of all these scales at once.
The earliest systematic biomechanics grew out of a practical need to describe how animals and humans move. Experimental and Motion-Analysis Biomechanics, which began in the 1870s, was not a theoretical framework but a methodological one: it used photography, cinematography, and direct measurement to capture the positions and timings of limbs during locomotion. Étienne-Jules Marey and Eadweard Muybridge, working independently, produced the first reliable records of gait, flight, and other motions. This framework never aimed to explain why a limb moves the way it does; it aimed to document how it moves, with enough precision to test hypotheses about gait and performance. It remains active today as the empirical backbone of sports biomechanics, rehabilitation analysis, and animal locomotion studies.
Rigid-Body and Musculoskeletal Biomechanics emerged alongside motion analysis but with a different ambition. Where experimental biomechanics recorded motion, rigid-body biomechanics sought to model it. Borrowing concepts from classical mechanics, researchers treated bones as rigid links connected by joints with defined degrees of freedom, and muscles as force generators acting along lines of action. Wilhelm Braune and Otto Fischer’s 1895 study of human gait, Der Gang des Menschen, exemplified this approach: they used cadavers to measure segment masses and centers of mass, then applied Newtonian mechanics to compute joint forces and moments. The rigid-body framework narrowed the problem by ignoring deformation entirely—bones were assumed inflexible, soft tissues were reduced to simple force vectors. This simplification made whole-body dynamics tractable and remains the standard approach for inverse dynamics in gait analysis today. The relationship between these two early frameworks was complementary: experimental motion analysis provided the kinematic data that rigid-body models required as input, while rigid-body models gave mechanical meaning to the observed motions.
By the mid-twentieth century, biomechanics faced a problem that rigid-body models could not address. Tissues like arteries, cartilage, and lung parenchyma are not rigid; they deform substantially under load, and their mechanical behavior is essential to their biological function. Continuum Biomechanics, introduced systematically by Y. C. Fung and others in the 1960s and 1970s, replaced the rigid-link assumption with the mathematics of continuous deformable media. Instead of treating a bone as a rigid body, continuum biomechanics described it as a solid with constitutive equations relating stress and strain. Instead of modeling blood flow as bulk motion through rigid pipes, it treated vessels as deformable tubes with nonlinear wall properties. Fung’s 1967 paper on the elasticity of soft tissues in simple elongation demonstrated that skin, arteries, and other soft tissues exhibit a nonlinear stress-strain relationship that cannot be captured by linear elasticity or rigid-body assumptions. This was not a refinement of rigid-body biomechanics; it was a replacement of its core assumption about what biological structures are—deformable materials, not assemblages of rigid parts.
Computational and Finite-Element Biomechanics arrived almost simultaneously, beginning in the early 1970s, and provided the practical tool that made continuum biomechanics applicable to real anatomical geometries. The finite-element method, originally developed for aerospace and civil engineering, was adapted to biomechanics by researchers such as R. L. Piziali and Y. C. Fung, who in 1972 published a finite-element displacement analysis of a lung. Where continuum biomechanics supplied the governing equations, computational biomechanics supplied the numerical methods to solve them for irregular, three-dimensional structures like bones, joints, and organs. This framework transformed biomechanics from a field limited to simple geometries (spheres, cylinders, beams) into one that could model the actual shape of a femur or the complex fiber architecture of heart muscle. Computational biomechanics did not replace continuum theory; it absorbed and operationalized it, making continuum models the default language for tissue-level mechanics.
Soft-Tissue Viscoelasticity and Poroelasticity, which crystallized around 1980, refined the continuum approach for hydrated biological tissues. Continuum biomechanics had treated soft tissues as single-phase solids with nonlinear elasticity, but many tissues—cartilage, intervertebral discs, cornea—contain substantial fluid that moves through the solid matrix under load. Van C. Mow and his colleagues, in their 1980 paper on biphasic creep and stress relaxation of articular cartilage, introduced a poroelastic framework that modeled cartilage as a fluid-saturated porous solid. This was not a rejection of continuum biomechanics but a specialization: it added a second phase (fluid) and the interaction between fluid flow and solid deformation. The poroelastic framework explained phenomena that single-phase continuum models could not, such as the time-dependent creep and stress relaxation of cartilage under sustained load. It coexists with single-phase continuum models today, applied wherever tissue hydration and fluid transport are mechanically significant.
By the 1990s, biomechanics had become adept at describing the mechanical properties of tissues and predicting how they deform under load. But a deeper question pressed in: how do cells sense and respond to mechanical forces? Mechanobiology and Cell-Matrix Biomechanics, emerging around 1993, shifted the focus from tissue-level material properties to the cellular and molecular mechanisms of mechanotransduction. Where continuum and computational biomechanics treated cells as passive inclusions in a material, mechanobiology asked how cells actively remodel their cytoskeleton, adhere to the extracellular matrix, and convert mechanical signals into biochemical responses. Donald Ingber’s cellular tensegrity model, published in 1993, proposed that the cytoskeleton maintains its shape through a balance of tension and compression, much like a tensegrity structure. This framework challenged the passive-material view of earlier frameworks: cells are not just bits of tissue with measurable stiffness; they are active, adaptive systems that regulate their own mechanics. Mechanobiology did not replace continuum biomechanics—tissue-level continuum models remain essential for understanding joint mechanics, arterial wall stress, and implant design. Instead, it added a new layer of explanation at a smaller scale, creating a division of labor: continuum models describe the mechanical environment, while mechanobiology explains how cells interpret and respond to that environment.
Multiscale Biomechanics, which emerged around 2006, is the most recent framework and the most ambitious. It arose from a growing recognition that the field had fragmented by scale: molecular biomechanics, cell mechanics, tissue mechanics, and organ-level mechanics were pursued by separate communities using separate methods, with little integration. Multiscale biomechanics aims to build models that link behavior across scales—for example, connecting molecular-level cross-bridge dynamics in cardiac muscle to whole-heart pumping function. The 2006 paper on multiscale modelling in biofluidynamics applied to reconstructive paediatric cardiac surgery exemplified this approach, coupling fluid dynamics at the organ scale with tissue-level material properties and cellular-level responses. Multiscale biomechanics is not a single method but a methodological commitment to integration: it uses hierarchical modeling, parameter passing between scales, and computational frameworks that can handle the vastly different time and length scales involved. It remains an active frontier, not yet a settled paradigm, because the computational and conceptual challenges of true scale integration are formidable.
Today, all seven frameworks remain active, but they occupy different niches. Experimental motion analysis and rigid-body musculoskeletal modeling dominate clinical gait analysis and sports biomechanics. Continuum and computational finite-element biomechanics are the standard tools for implant design, injury prediction, and surgical planning. Soft-tissue poroelasticity is essential for understanding cartilage, intervertebral discs, and other hydrated tissues. Mechanobiology has become central to tissue engineering, cancer research, and developmental biology. Multiscale biomechanics is the aspirational framework, still seeking methods that can genuinely bridge scales without losing fidelity.
What the leading frameworks agree on is that biological mechanics must be grounded in quantitative, experimentally validated models, and that mechanical forces are not incidental but essential to biological function. Where they disagree is on the appropriate level of abstraction. Computational and continuum biomechanists often argue that tissue-level constitutive models, validated against macroscopic experiments, are sufficient for most engineering applications. Mechanobiologists counter that ignoring cellular activity misses the fundamental regulatory role of mechanics in living systems. Multiscale advocates argue that neither scale alone is adequate and that integration is the only path forward. This disagreement is not a sign of weakness; it reflects the genuine complexity of biological systems, where different questions demand different frameworks. The history of biomechanics is not a story of one framework triumphing over others, but of a field that has steadily expanded its repertoire of tools and concepts, each framework adding a new way of seeing how living things handle force. The challenge for the next generation is not to pick a winner but to decide when and how to move between frameworks, and whether a truly unified biomechanics is possible or even desirable.